These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study. Tsoumpou I, Valasoulis G, Founta C, Kyrgiou M, Nasioutziki M, Daponte A, Koliopoulos G, Malamou-Mitsi V, Karakitsos P, Paraskevaidis E. Gynecol Oncol; 2011 Apr; 121(1):49-53. PubMed ID: 21194734 [Abstract] [Full Text] [Related]
27. Prognostic value of p16(INK4a) as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 (CIN 3) treated by cervical conization. Cardoso FA, Campaner AB, Silva MA. APMIS; 2014 Mar; 122(3):192-9. PubMed ID: 23763281 [Abstract] [Full Text] [Related]
28. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia. Kalof AN, Evans MF, Simmons-Arnold L, Beatty BG, Cooper K. Am J Surg Pathol; 2005 May; 29(5):674-9. PubMed ID: 15832093 [Abstract] [Full Text] [Related]
29. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study. Razmpoosh M, Sansregret A, Oligny LL, Patey N, Dormoy-Raclet V, Ducruet T, Bouron-Dal Soglio D. Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093 [Abstract] [Full Text] [Related]
30. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ. J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437 [Abstract] [Full Text] [Related]
31. p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia. Samarawardana P, Dehn DL, Singh M, Franquemont D, Thompson C, Gaido L, Torkko KC, Homer P, Burke S, Titmus MA, Nayi V, Shroyer KR. Cancer Cytopathol; 2010 Jun 25; 118(3):146-56. PubMed ID: 20544710 [Abstract] [Full Text] [Related]
34. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study. Fallani MG, Penna C, Marchionni M, Bussani C, Pieralli A, Andersson KL, Fambrini M. Eur J Gynaecol Oncol; 2008 Jun 25; 29(4):378-82. PubMed ID: 18714574 [Abstract] [Full Text] [Related]
35. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women. Lin ZH, Shen XH, Jin Z, Kim Y, Lee E, Kim H, Kim I. Pathol Int; 2005 Aug 25; 55(8):491-6. PubMed ID: 15998377 [Abstract] [Full Text] [Related]
36. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion. Koo YJ, Hahn HS, Lee IH, Lim KT, Lee KH, Kim HS, Kim TJ, Chun YK, Kim HS, Hong SR. Virchows Arch; 2013 Nov 25; 463(5):689-96. PubMed ID: 24081504 [Abstract] [Full Text] [Related]
37. The triage of low-grade cytological abnormalities by the immunocytological expression of cyclin-dependent kinase inhibitor p16INK4a versus Human Papillomavirus test: a real possibility to predict cervical intraepithelial neoplasia CIN2 or CIN2+. Stănculescu R, Brătilă E, Bauşic V, Vlădescu T. Rom J Morphol Embryol; 2013 Nov 25; 54(4):1061-5. PubMed ID: 24399002 [Abstract] [Full Text] [Related]